We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Increased NIV Molecular Imaging Technologies Needed for Cancer Care

By MedImaging International staff writers
Posted on 10 Jan 2017
Print article
Image: The image on the left is from before therapy, and the image on the right from three days after treatment (Photo courtesy of Penn Medicine).
Image: The image on the left is from before therapy, and the image on the right from three days after treatment (Photo courtesy of Penn Medicine).
According to researchers in the US, new molecular imaging technologies can facilitate the diagnosis, monitoring, and treatment of cancer, while at the same time reducing the frequency of unnecessary or ineffective therapies and minimizing side effects.

The new non-invasive molecular imaging technology can also complement biopsy data in cancer care, in cases where multiple examinations are necessary.

The researchers from the Abramson Cancer Center (PENN Medicine; Philadelphia, PA, USA), and the Perelman School of Medicine, University of Pennsylvania, (Philadelphia, PA, USA) published the review online on December 29, 2016, in the journal JAMA Oncology.

According to the authors, molecular imaging can have several significant impacts. These include helping identify patients that would benefit from targeted therapy, monitoring drug movement in the body and helping to guide drug dosing while minimizing side effects. Molecular imaging can also be used to monitor the effectiveness of drug treatments. The combined data can help predict patient outcomes and overall survival.

Lead author of the study, David A. Mankoff, MD, PhD, said, "Many of these methods are already being studied in clinical trials, but the path from clinical trials to routine clinical use is seldom easy. Molecular imaging methods face some particularly challenging hurdles such as the need to deliver the short-lived imaging probes to centers performing the imaging. We don't have a good framework yet for moving these potentially powerful diagnostic tools into routine clinical use. Among other things, we need to bring the imaging and oncology communities together to find the best way forward. In that case, molecular imaging could have directed treatment to patients highly likely to benefit and spared many other patients the toxic effects and costs of ineffective therapy."

Related Links:
Abramson Cancer Center
Perelman School of Medicine
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound System
Acclarix AX9
New
C-Arm with FPD
Digiscan V20 / V30
New
Ultrasound Software
UltraExtend NX

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.